10x Genomics Inc.
- BID
37.78
- ASK
37.87
- 1,323 Units264 Units
- 07/20, 21:59:58 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
253.40%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.31 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 37.73 G | 0 Units |
| PRICE DETERMINATION TIME | 07/20/2026 / 09:56:27 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 38.27 | 37.115 |
| PREV. DAY'S PRICE | 38.22 | (07/17) |
| CHANGE DAY BEFORE | -0.49 | -1.28 % |
| 52 WEEK HIGH / LOW | 40.07 (07/15) | 9.468 (09/30) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -2.01 | -1.40 | -0.31 | -0.67 | -0.56 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 8.99 | 2.47 | 2.62 | - | - |
PRICE - SALES RATIO | 10.60 | 2.83 | 3.17 | - | - |
PRICE - CASH FLOW RATIO | - | 259.56 | 14.96 | - | - |
Master Data
| WKN | A2PPQJ |
| ISIN | US88025U1097 |
| SYMBOL | 1KJ |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | 10X GENOMICS DL -,00001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 3.10 % | 36.18 % | 73.73 % | 115.87 % | 253.40 % | -26.47 % | -73.26 % | 184.69 % |
| HIGH | 40.07 | 40.07 | 40.07 | 40.07 | 40.07 | 56.66 | 158.80 | 40.07 |
| LOW | 36.01 | 27.51 | 16.75 | 13.96 | 9.47 | 6.11 | 6.11 | 13.68 |
Dividende
pro Aktie
10X GENOMICS DL -,00001 does not deliver dividend information
Company profile
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Structured products for 10x Genomics Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.